Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis | 45 | 2024 | 945 | 2.440 |
Why?
|
Veins | 29 | 2017 | 765 | 1.990 |
Why?
|
Ischemia | 35 | 2017 | 1897 | 1.760 |
Why?
|
Leg | 40 | 2003 | 1091 | 1.720 |
Why?
|
Polyethylene Terephthalates | 22 | 2014 | 115 | 1.710 |
Why?
|
Muscle, Smooth, Vascular | 14 | 2016 | 1484 | 1.650 |
Why?
|
RNA, Small Interfering | 15 | 2024 | 3442 | 1.530 |
Why?
|
Diabetic Angiopathies | 29 | 2013 | 822 | 1.490 |
Why?
|
Myocytes, Smooth Muscle | 6 | 2024 | 685 | 1.450 |
Why?
|
Foot | 21 | 2005 | 573 | 1.140 |
Why?
|
Saphenous Vein | 20 | 2010 | 538 | 1.000 |
Why?
|
Gene Silencing | 6 | 2016 | 1511 | 0.980 |
Why?
|
Hirudins | 9 | 2024 | 194 | 0.960 |
Why?
|
Aorta | 9 | 2016 | 2042 | 0.910 |
Why?
|
Vascular Surgical Procedures | 26 | 2007 | 1471 | 0.880 |
Why?
|
Peripheral Vascular Diseases | 12 | 2007 | 516 | 0.880 |
Why?
|
Biocompatible Materials | 11 | 2010 | 1688 | 0.860 |
Why?
|
Angioplasty | 4 | 2017 | 360 | 0.840 |
Why?
|
Arteries | 17 | 2017 | 1126 | 0.830 |
Why?
|
Diabetes Complications | 17 | 2007 | 1342 | 0.800 |
Why?
|
Limb Salvage | 8 | 2017 | 468 | 0.780 |
Why?
|
Femoral Artery | 29 | 2007 | 838 | 0.780 |
Why?
|
Endothelium, Vascular | 17 | 2012 | 4437 | 0.760 |
Why?
|
Transfection | 7 | 2024 | 5782 | 0.750 |
Why?
|
Arterial Occlusive Diseases | 18 | 2006 | 752 | 0.730 |
Why?
|
Vascular Patency | 29 | 2024 | 904 | 0.690 |
Why?
|
Blood Vessel Prosthesis Implantation | 19 | 2024 | 1426 | 0.680 |
Why?
|
Arm | 13 | 2000 | 583 | 0.680 |
Why?
|
Arteriosclerosis | 16 | 2002 | 1064 | 0.680 |
Why?
|
Lower Extremity | 7 | 2024 | 1196 | 0.650 |
Why?
|
Diabetic Neuropathies | 13 | 2015 | 406 | 0.620 |
Why?
|
Diabetic Foot | 11 | 2005 | 381 | 0.610 |
Why?
|
Popliteal Artery | 19 | 2006 | 315 | 0.600 |
Why?
|
Tunica Intima | 9 | 2014 | 459 | 0.590 |
Why?
|
Polyurethanes | 6 | 2005 | 108 | 0.590 |
Why?
|
Ciprofloxacin | 7 | 2010 | 312 | 0.580 |
Why?
|
Wound Healing | 10 | 2015 | 2785 | 0.580 |
Why?
|
Thrombospondins | 3 | 2024 | 193 | 0.550 |
Why?
|
Graft Occlusion, Vascular | 14 | 2005 | 560 | 0.540 |
Why?
|
Carotid Stenosis | 6 | 2008 | 872 | 0.540 |
Why?
|
RNA Interference | 5 | 2014 | 2845 | 0.530 |
Why?
|
Hyperplasia | 15 | 2024 | 1158 | 0.510 |
Why?
|
Endarterectomy, Carotid | 6 | 2003 | 560 | 0.510 |
Why?
|
Stents | 7 | 2017 | 3306 | 0.490 |
Why?
|
Neuropeptides | 5 | 2013 | 941 | 0.480 |
Why?
|
Polyethyleneimine | 2 | 2016 | 67 | 0.480 |
Why?
|
Polytetrafluoroethylene | 12 | 2002 | 245 | 0.470 |
Why?
|
Carotid Arteries | 11 | 2002 | 951 | 0.470 |
Why?
|
Cell Adhesion | 9 | 2014 | 3096 | 0.460 |
Why?
|
Dogs | 23 | 2024 | 3842 | 0.460 |
Why?
|
Coated Materials, Biocompatible | 2 | 2014 | 319 | 0.420 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2874 | 0.420 |
Why?
|
Angioscopy | 4 | 2000 | 48 | 0.410 |
Why?
|
Vascular Diseases | 8 | 2009 | 1180 | 0.410 |
Why?
|
Cell-Matrix Junctions | 1 | 2011 | 21 | 0.390 |
Why?
|
Foot Diseases | 6 | 1992 | 147 | 0.370 |
Why?
|
Thrombin | 7 | 2005 | 593 | 0.370 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2015 | 1109 | 0.370 |
Why?
|
Peripheral Arterial Disease | 2 | 2024 | 1316 | 0.360 |
Why?
|
Cell Movement | 8 | 2011 | 5210 | 0.340 |
Why?
|
Anastomosis, Surgical | 11 | 2007 | 983 | 0.340 |
Why?
|
Life Tables | 8 | 2017 | 365 | 0.340 |
Why?
|
Microcirculation | 12 | 2002 | 1279 | 0.320 |
Why?
|
Antithrombins | 4 | 2024 | 313 | 0.320 |
Why?
|
Substance P | 4 | 2015 | 333 | 0.300 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1189 | 0.300 |
Why?
|
Bacterial Infections | 4 | 2005 | 1402 | 0.290 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2002 | 0.280 |
Why?
|
Intracranial Embolism | 1 | 2008 | 192 | 0.280 |
Why?
|
Foot Ulcer | 2 | 1999 | 63 | 0.270 |
Why?
|
Skin Ulcer | 4 | 2013 | 129 | 0.260 |
Why?
|
Device Approval | 1 | 2007 | 165 | 0.260 |
Why?
|
Leiomyomatosis | 1 | 2005 | 69 | 0.250 |
Why?
|
Prosthesis-Related Infections | 2 | 2005 | 486 | 0.250 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 943 | 0.250 |
Why?
|
Coronary Vessels | 3 | 2012 | 3112 | 0.250 |
Why?
|
Diabetes Mellitus | 14 | 2011 | 5884 | 0.240 |
Why?
|
Muscle Proteins | 2 | 2001 | 1152 | 0.240 |
Why?
|
Arteriovenous Shunt, Surgical | 6 | 1992 | 294 | 0.230 |
Why?
|
Anti-Infective Agents | 4 | 2010 | 980 | 0.230 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 167 | 0.230 |
Why?
|
Gene Expression | 4 | 2004 | 7592 | 0.230 |
Why?
|
Flow Cytometry | 2 | 2012 | 5873 | 0.230 |
Why?
|
Vena Cava, Inferior | 3 | 2005 | 458 | 0.220 |
Why?
|
Bandages | 1 | 2005 | 269 | 0.220 |
Why?
|
Serum Albumin, Bovine | 6 | 2002 | 323 | 0.220 |
Why?
|
Cerebral Infarction | 1 | 2008 | 982 | 0.220 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2002 | 1880 | 0.220 |
Why?
|
Polyesters | 2 | 2010 | 372 | 0.210 |
Why?
|
Popliteal Vein | 3 | 2000 | 43 | 0.210 |
Why?
|
Humans | 171 | 2024 | 760276 | 0.210 |
Why?
|
Cerebrovascular Disorders | 4 | 1999 | 1500 | 0.210 |
Why?
|
Coronary Disease | 4 | 2002 | 5993 | 0.210 |
Why?
|
Surface Properties | 8 | 2005 | 1158 | 0.200 |
Why?
|
Cadherins | 1 | 2007 | 898 | 0.200 |
Why?
|
Femoral Vein | 3 | 2000 | 153 | 0.200 |
Why?
|
Cysteine Endopeptidases | 2 | 2001 | 548 | 0.200 |
Why?
|
Heart Neoplasms | 1 | 2005 | 361 | 0.200 |
Why?
|
Angioplasty, Balloon | 4 | 2016 | 600 | 0.200 |
Why?
|
Gelatin | 1 | 2024 | 221 | 0.200 |
Why?
|
Cell Proliferation | 7 | 2024 | 10439 | 0.200 |
Why?
|
Time Factors | 26 | 2017 | 40141 | 0.190 |
Why?
|
Neuropeptide Y | 3 | 2011 | 191 | 0.190 |
Why?
|
Multienzyme Complexes | 2 | 2001 | 666 | 0.190 |
Why?
|
Platelet Activation | 3 | 1995 | 661 | 0.190 |
Why?
|
Cell Division | 5 | 2002 | 4462 | 0.180 |
Why?
|
Blood Coagulation | 2 | 2005 | 1156 | 0.180 |
Why?
|
Arginine | 1 | 2024 | 934 | 0.180 |
Why?
|
Cells, Cultured | 12 | 2011 | 18968 | 0.180 |
Why?
|
Venous Cutdown | 1 | 2000 | 5 | 0.180 |
Why?
|
Cytokines | 3 | 2013 | 7346 | 0.180 |
Why?
|
Vascular System Injuries | 1 | 2024 | 248 | 0.180 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 11902 | 0.170 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5793 | 0.170 |
Why?
|
Celiac Artery | 1 | 2000 | 65 | 0.170 |
Why?
|
Heel | 1 | 1999 | 37 | 0.170 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2274 | 0.170 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1108 | 0.170 |
Why?
|
Aged | 68 | 2017 | 169002 | 0.160 |
Why?
|
Endothelial Cells | 3 | 2024 | 3537 | 0.160 |
Why?
|
Vasodilation | 6 | 2002 | 964 | 0.160 |
Why?
|
Estradiol Congeners | 1 | 1998 | 23 | 0.160 |
Why?
|
Certification | 1 | 2002 | 423 | 0.160 |
Why?
|
Animals | 42 | 2024 | 167935 | 0.150 |
Why?
|
RNA, Messenger | 7 | 2014 | 12763 | 0.150 |
Why?
|
Blood Flow Velocity | 7 | 1998 | 1375 | 0.150 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9590 | 0.150 |
Why?
|
Staphylococcal Infections | 2 | 2005 | 1405 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2004 | 3774 | 0.150 |
Why?
|
Proteins | 3 | 2001 | 6030 | 0.150 |
Why?
|
Cell Count | 2 | 2012 | 1838 | 0.150 |
Why?
|
Axillary Artery | 3 | 1992 | 48 | 0.140 |
Why?
|
Rabbits | 6 | 2015 | 4773 | 0.140 |
Why?
|
Interleukin-8 | 2 | 2011 | 698 | 0.140 |
Why?
|
Heparin | 1 | 2024 | 1656 | 0.140 |
Why?
|
Gastric Mucosa | 1 | 2000 | 599 | 0.140 |
Why?
|
Recombinant Proteins | 8 | 2024 | 6543 | 0.140 |
Why?
|
Prostheses and Implants | 3 | 2010 | 1272 | 0.140 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1494 | 0.140 |
Why?
|
Uterine Neoplasms | 1 | 2005 | 1434 | 0.140 |
Why?
|
Inflammation | 3 | 2015 | 10758 | 0.140 |
Why?
|
Postoperative Complications | 20 | 2007 | 15684 | 0.140 |
Why?
|
Female | 89 | 2024 | 391024 | 0.140 |
Why?
|
Reoperation | 13 | 2007 | 4293 | 0.140 |
Why?
|
Male | 86 | 2024 | 359427 | 0.140 |
Why?
|
Membrane Proteins | 3 | 2014 | 7854 | 0.130 |
Why?
|
Carotid Artery Injuries | 1 | 2016 | 96 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2003 | 3450 | 0.130 |
Why?
|
Models, Animal | 4 | 2007 | 2117 | 0.130 |
Why?
|
Materials Testing | 4 | 2005 | 857 | 0.130 |
Why?
|
Extremities | 5 | 2004 | 867 | 0.130 |
Why?
|
Regional Blood Flow | 6 | 2000 | 1490 | 0.130 |
Why?
|
Rheology | 6 | 1985 | 347 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 10343 | 0.130 |
Why?
|
Retrospective Studies | 39 | 2017 | 80311 | 0.130 |
Why?
|
Forearm | 6 | 2002 | 429 | 0.130 |
Why?
|
Skin | 8 | 2015 | 4467 | 0.120 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2015 | 132 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2024 | 1618 | 0.120 |
Why?
|
Estrogen Replacement Therapy | 2 | 1999 | 1207 | 0.120 |
Why?
|
Carboxylic Acids | 4 | 2005 | 90 | 0.120 |
Why?
|
Models, Anatomic | 3 | 1990 | 682 | 0.120 |
Why?
|
Methacrylates | 1 | 2015 | 109 | 0.120 |
Why?
|
Carotid Artery, Internal | 5 | 2003 | 438 | 0.120 |
Why?
|
Adsorption | 2 | 2014 | 197 | 0.120 |
Why?
|
Tissue Preservation | 3 | 1992 | 174 | 0.120 |
Why?
|
Follow-Up Studies | 23 | 2006 | 39256 | 0.110 |
Why?
|
Up-Regulation | 4 | 2013 | 4127 | 0.110 |
Why?
|
Actuarial Analysis | 5 | 1992 | 375 | 0.110 |
Why?
|
Methods | 10 | 1996 | 1075 | 0.110 |
Why?
|
Plant Lectins | 1 | 1993 | 103 | 0.110 |
Why?
|
Metatarsus | 1 | 1993 | 18 | 0.110 |
Why?
|
Ultrasonics | 3 | 1991 | 207 | 0.110 |
Why?
|
Glycoconjugates | 1 | 1993 | 88 | 0.110 |
Why?
|
Aged, 80 and over | 19 | 2007 | 58953 | 0.110 |
Why?
|
Gangrene | 5 | 1999 | 91 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2368 | 0.110 |
Why?
|
Interferon-gamma | 2 | 1999 | 3161 | 0.110 |
Why?
|
Endothelial Growth Factors | 3 | 2002 | 674 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2015 | 2509 | 0.100 |
Why?
|
Cross-Linking Reagents | 4 | 1997 | 685 | 0.100 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2477 | 0.100 |
Why?
|
Cell Shape | 1 | 2014 | 372 | 0.100 |
Why?
|
Brachiocephalic Veins | 1 | 1992 | 21 | 0.100 |
Why?
|
Microscopy, Electron, Scanning | 6 | 1995 | 940 | 0.100 |
Why?
|
Pulse | 2 | 1986 | 218 | 0.100 |
Why?
|
Kidney Failure, Chronic | 4 | 2004 | 2469 | 0.100 |
Why?
|
Middle Aged | 60 | 2011 | 220179 | 0.100 |
Why?
|
Peripheral Nerves | 1 | 1996 | 475 | 0.100 |
Why?
|
Lymphokines | 3 | 2002 | 929 | 0.100 |
Why?
|
Survival Analysis | 9 | 2007 | 10185 | 0.100 |
Why?
|
Treatment Outcome | 20 | 2024 | 64968 | 0.100 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2011 | 46 | 0.100 |
Why?
|
Angiography | 7 | 1999 | 1605 | 0.100 |
Why?
|
Salvage Therapy | 3 | 2000 | 1266 | 0.100 |
Why?
|
Tensile Strength | 3 | 2005 | 331 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 1998 | 2414 | 0.100 |
Why?
|
Lectins | 1 | 1993 | 485 | 0.100 |
Why?
|
Blood Physiological Phenomena | 1 | 1991 | 53 | 0.100 |
Why?
|
Estrogens | 1 | 1998 | 1520 | 0.100 |
Why?
|
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2010 | 5 | 0.090 |
Why?
|
Protein Binding | 7 | 2001 | 9336 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2003 | 12280 | 0.090 |
Why?
|
Air Pressure | 1 | 2010 | 74 | 0.090 |
Why?
|
Genes | 1 | 1995 | 1845 | 0.090 |
Why?
|
Nitroprusside | 6 | 2002 | 273 | 0.090 |
Why?
|
General Surgery | 1 | 2002 | 1681 | 0.090 |
Why?
|
Tibial Arteries | 3 | 2002 | 60 | 0.090 |
Why?
|
Acetylcholine | 7 | 2002 | 629 | 0.090 |
Why?
|
Photomicrography | 1 | 1990 | 71 | 0.090 |
Why?
|
Length of Stay | 7 | 2005 | 6474 | 0.090 |
Why?
|
Aortic Aneurysm | 2 | 2014 | 646 | 0.090 |
Why?
|
Indicators and Reagents | 1 | 2011 | 461 | 0.090 |
Why?
|
Alloxan | 1 | 2009 | 13 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1249 | 0.090 |
Why?
|
Survival Rate | 11 | 2005 | 12806 | 0.090 |
Why?
|
Blood Circulation | 2 | 1981 | 249 | 0.090 |
Why?
|
Fluorescence | 1 | 2012 | 750 | 0.090 |
Why?
|
Risk Factors | 20 | 2024 | 74278 | 0.090 |
Why?
|
Inflammation Mediators | 3 | 2014 | 1882 | 0.090 |
Why?
|
Carotid Artery Diseases | 4 | 2003 | 881 | 0.090 |
Why?
|
Creatinine | 3 | 2006 | 1907 | 0.080 |
Why?
|
Aneurysm | 2 | 2004 | 337 | 0.080 |
Why?
|
Prosthesis Design | 4 | 1998 | 2127 | 0.080 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 290 | 0.080 |
Why?
|
Quality Control | 1 | 2012 | 827 | 0.080 |
Why?
|
Thrombophlebitis | 2 | 1989 | 289 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 462 | 0.080 |
Why?
|
Iontophoresis | 5 | 2001 | 74 | 0.080 |
Why?
|
Textiles | 3 | 2010 | 45 | 0.080 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 1991 | 170 | 0.080 |
Why?
|
Surgical Instruments | 1 | 1991 | 385 | 0.080 |
Why?
|
Tissue Scaffolds | 1 | 2015 | 927 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4573 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6546 | 0.080 |
Why?
|
Monitoring, Intraoperative | 2 | 1993 | 941 | 0.080 |
Why?
|
Growth Substances | 2 | 2014 | 768 | 0.080 |
Why?
|
Macrophages | 4 | 2016 | 5746 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6830 | 0.070 |
Why?
|
Cloning, Molecular | 3 | 1999 | 4172 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 319 | 0.070 |
Why?
|
Analgesia, Epidural | 1 | 1991 | 330 | 0.070 |
Why?
|
Calcinosis | 1 | 1996 | 1478 | 0.070 |
Why?
|
Hyperglycemia | 2 | 2011 | 1380 | 0.070 |
Why?
|
Platelet Aggregation | 4 | 1991 | 805 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2015 | 1849 | 0.070 |
Why?
|
Diabetic Nephropathies | 1 | 1994 | 988 | 0.070 |
Why?
|
Hemodynamics | 5 | 1998 | 4169 | 0.070 |
Why?
|
Inguinal Canal | 2 | 2005 | 72 | 0.070 |
Why?
|
Porosity | 2 | 2015 | 349 | 0.070 |
Why?
|
Molecular Chaperones | 2 | 2001 | 752 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1998 | 1544 | 0.070 |
Why?
|
Voluntary Health Agencies | 1 | 1986 | 38 | 0.070 |
Why?
|
Blood Platelets | 3 | 1995 | 2522 | 0.070 |
Why?
|
Transplantation, Autologous | 8 | 2000 | 2121 | 0.070 |
Why?
|
Ultrasonography | 6 | 1996 | 5960 | 0.070 |
Why?
|
Oxygen | 2 | 2015 | 4190 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2009 | 4361 | 0.070 |
Why?
|
Aorta, Abdominal | 5 | 1995 | 622 | 0.070 |
Why?
|
Blotting, Western | 2 | 2007 | 5039 | 0.070 |
Why?
|
Contusions | 1 | 1986 | 81 | 0.060 |
Why?
|
Ethylenediamines | 1 | 2005 | 57 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2001 | 1314 | 0.060 |
Why?
|
Iliac Artery | 2 | 1985 | 344 | 0.060 |
Why?
|
Cell Death | 1 | 2011 | 1670 | 0.060 |
Why?
|
Intraoperative Care | 4 | 2000 | 768 | 0.060 |
Why?
|
Spectrophotometry | 1 | 2005 | 311 | 0.060 |
Why?
|
Heart Atria | 1 | 2011 | 1344 | 0.060 |
Why?
|
Methylene Blue | 1 | 2005 | 152 | 0.060 |
Why?
|
Immunohistochemistry | 6 | 2002 | 11064 | 0.060 |
Why?
|
Adult | 38 | 2006 | 219843 | 0.060 |
Why?
|
Prosthesis Failure | 4 | 2001 | 1206 | 0.060 |
Why?
|
Polymers | 2 | 2005 | 1620 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3806 | 0.060 |
Why?
|
Transplantation | 1 | 1986 | 218 | 0.060 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2024 | 78 | 0.060 |
Why?
|
Radiography | 9 | 2004 | 6965 | 0.060 |
Why?
|
Spasm | 1 | 1984 | 131 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2710 | 0.060 |
Why?
|
Cell-Penetrating Peptides | 1 | 2024 | 49 | 0.060 |
Why?
|
Heart Function Tests | 1 | 2005 | 319 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 1994 | 2168 | 0.060 |
Why?
|
Pipecolic Acids | 1 | 2024 | 78 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1336 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3242 | 0.060 |
Why?
|
Glycoproteins | 2 | 2001 | 2208 | 0.060 |
Why?
|
Computational Biology | 1 | 2016 | 3504 | 0.060 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 328 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 3 | 2002 | 749 | 0.050 |
Why?
|
Models, Chemical | 1 | 2005 | 614 | 0.050 |
Why?
|
Infection Control | 1 | 2010 | 983 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 1999 | 17628 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1914 | 0.050 |
Why?
|
Polyethylenes | 1 | 2005 | 290 | 0.050 |
Why?
|
Chromans | 1 | 2003 | 117 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3846 | 0.050 |
Why?
|
Vasodilator Agents | 4 | 2002 | 977 | 0.050 |
Why?
|
Brachial Artery | 3 | 1998 | 368 | 0.050 |
Why?
|
Lasers | 1 | 1987 | 952 | 0.050 |
Why?
|
Coloring Agents | 3 | 2010 | 561 | 0.050 |
Why?
|
Graft Survival | 5 | 2005 | 3793 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2002 | 95 | 0.050 |
Why?
|
Cattle | 3 | 1999 | 3847 | 0.050 |
Why?
|
Registries | 7 | 2005 | 8450 | 0.050 |
Why?
|
Adenosine Triphosphate | 3 | 1995 | 1995 | 0.050 |
Why?
|
Rats | 3 | 2024 | 23697 | 0.050 |
Why?
|
Blood Vessels | 3 | 1985 | 1112 | 0.050 |
Why?
|
Credentialing | 1 | 2002 | 115 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2009 | 18135 | 0.050 |
Why?
|
Complement Inactivator Proteins | 1 | 2001 | 77 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2001 | 256 | 0.050 |
Why?
|
Recurrence | 4 | 2002 | 8487 | 0.050 |
Why?
|
Health Services Research | 1 | 2009 | 1811 | 0.050 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 445 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3783 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2024 | 377 | 0.050 |
Why?
|
Iliac Aneurysm | 1 | 2001 | 37 | 0.050 |
Why?
|
Cell Cycle | 2 | 2007 | 2936 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2005 | 3469 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 428 | 0.050 |
Why?
|
Down-Regulation | 2 | 2013 | 2919 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 1999 | 694 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2001 | 617 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 1996 | 2852 | 0.040 |
Why?
|
Extracellular Matrix | 2 | 2001 | 1726 | 0.040 |
Why?
|
Forefoot, Human | 1 | 1999 | 32 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2003 | 465 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2009 | 3207 | 0.040 |
Why?
|
Nitric Oxide Synthase | 2 | 2002 | 908 | 0.040 |
Why?
|
Videotape Recording | 2 | 1991 | 337 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2002 | 3604 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2024 | 730 | 0.040 |
Why?
|
Vasomotor System | 1 | 1999 | 207 | 0.040 |
Why?
|
Reflex | 1 | 2001 | 376 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 135 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 1992 | 2558 | 0.040 |
Why?
|
Antibodies | 1 | 2007 | 2424 | 0.040 |
Why?
|
Heart Failure | 5 | 2011 | 11836 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2002 | 671 | 0.040 |
Why?
|
Ischemic Attack, Transient | 2 | 2003 | 899 | 0.040 |
Why?
|
Chemotaxis | 1 | 2001 | 598 | 0.040 |
Why?
|
Incidence | 4 | 2002 | 21379 | 0.040 |
Why?
|
Endoscopy | 3 | 1995 | 1841 | 0.040 |
Why?
|
Tyrosine | 1 | 2002 | 1440 | 0.040 |
Why?
|
Specialty Boards | 1 | 2000 | 235 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2000 | 279 | 0.040 |
Why?
|
Platelet Count | 2 | 1991 | 777 | 0.040 |
Why?
|
Organ Preservation | 1 | 1981 | 379 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2014 | 3524 | 0.040 |
Why?
|
Polycarboxylate Cement | 1 | 1997 | 18 | 0.040 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1998 | 239 | 0.040 |
Why?
|
Drug Stability | 1 | 1998 | 290 | 0.040 |
Why?
|
Treatment Failure | 2 | 1995 | 2646 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1576 | 0.040 |
Why?
|
Intraoperative Period | 2 | 1990 | 516 | 0.040 |
Why?
|
Thrombosis | 8 | 1999 | 3053 | 0.040 |
Why?
|
Biological Availability | 1 | 1998 | 395 | 0.040 |
Why?
|
Wrist | 1 | 1979 | 219 | 0.040 |
Why?
|
Logistic Models | 6 | 2006 | 13315 | 0.040 |
Why?
|
Manometry | 1 | 2000 | 453 | 0.040 |
Why?
|
DNA Probes | 1 | 1998 | 551 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2001 | 1032 | 0.040 |
Why?
|
Bioprosthesis | 1 | 1981 | 599 | 0.040 |
Why?
|
Maleimides | 1 | 1997 | 114 | 0.040 |
Why?
|
Cytoplasm | 1 | 2001 | 1517 | 0.030 |
Why?
|
Mitral Valve | 1 | 2005 | 1487 | 0.030 |
Why?
|
Risk Assessment | 2 | 2017 | 24086 | 0.030 |
Why?
|
Residence Characteristics | 2 | 1998 | 2058 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 590 | 0.030 |
Why?
|
Rehabilitation Centers | 1 | 1998 | 248 | 0.030 |
Why?
|
Ubiquitin | 1 | 2001 | 840 | 0.030 |
Why?
|
Tissue Donors | 1 | 1986 | 2314 | 0.030 |
Why?
|
Cell Adhesion Molecules | 2 | 1999 | 1602 | 0.030 |
Why?
|
United States | 7 | 2009 | 72369 | 0.030 |
Why?
|
Morbidity | 2 | 2003 | 1765 | 0.030 |
Why?
|
Severity of Illness Index | 4 | 2006 | 15828 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1977 | 185 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1100 | 0.030 |
Why?
|
Sphincter of Oddi | 1 | 1975 | 21 | 0.030 |
Why?
|
Models, Biological | 3 | 1982 | 9468 | 0.030 |
Why?
|
Homes for the Aged | 1 | 1998 | 268 | 0.030 |
Why?
|
Cohort Studies | 8 | 2005 | 41316 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2777 | 0.030 |
Why?
|
Base Sequence | 2 | 1999 | 12447 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 129 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20045 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4357 | 0.030 |
Why?
|
Thiazoles | 1 | 2003 | 1509 | 0.030 |
Why?
|
Endothelium | 3 | 1983 | 764 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 1980 | 973 | 0.030 |
Why?
|
GATA4 Transcription Factor | 1 | 2016 | 124 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 1999 | 1097 | 0.030 |
Why?
|
Staphylococcus aureus | 2 | 1993 | 1462 | 0.030 |
Why?
|
Ampulla of Vater | 1 | 1975 | 147 | 0.030 |
Why?
|
Intestinal Polyps | 1 | 1975 | 104 | 0.030 |
Why?
|
Medicare | 1 | 1993 | 6771 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3822 | 0.030 |
Why?
|
Biliary Tract Diseases | 1 | 1975 | 156 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 1996 | 166 | 0.030 |
Why?
|
Phenotype | 2 | 2008 | 16543 | 0.030 |
Why?
|
Kidney Transplantation | 3 | 2003 | 4215 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 1998 | 536 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2000 | 604 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2000 | 787 | 0.030 |
Why?
|
Chromogenic Compounds | 1 | 1994 | 31 | 0.030 |
Why?
|
Evaluation Studies as Topic | 3 | 1999 | 1628 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 2005 | 2253 | 0.030 |
Why?
|
Ophthalmic Artery | 1 | 1974 | 58 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1973 | 0.030 |
Why?
|
Hematoma | 1 | 1999 | 769 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2104 | 0.030 |
Why?
|
Blood Cell Count | 1 | 1995 | 398 | 0.030 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 169 | 0.030 |
Why?
|
Cyclins | 1 | 1996 | 593 | 0.030 |
Why?
|
Plasminogen | 1 | 1994 | 146 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2002 | 3483 | 0.030 |
Why?
|
Serum Albumin | 1 | 1997 | 674 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 1994 | 645 | 0.030 |
Why?
|
Stroke Volume | 1 | 2007 | 5513 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1056 | 0.030 |
Why?
|
Hydrolysis | 1 | 1995 | 665 | 0.030 |
Why?
|
Papaverine | 2 | 1984 | 45 | 0.030 |
Why?
|
Drug Interactions | 1 | 1998 | 1426 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3421 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 670 | 0.030 |
Why?
|
Perfusion | 1 | 1998 | 1376 | 0.030 |
Why?
|
Renal Dialysis | 5 | 2006 | 1802 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3278 | 0.030 |
Why?
|
Growth Inhibitors | 1 | 2014 | 378 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 633 | 0.030 |
Why?
|
Myocardial Infarction | 4 | 2005 | 11894 | 0.030 |
Why?
|
Amputation Stumps | 1 | 1993 | 38 | 0.030 |
Why?
|
Quality of Life | 1 | 1995 | 13301 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 202 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2015 | 428 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 1994 | 299 | 0.030 |
Why?
|
Creatine Kinase | 1 | 1995 | 691 | 0.030 |
Why?
|
Axons | 1 | 2001 | 1672 | 0.030 |
Why?
|
Case-Control Studies | 4 | 1999 | 22040 | 0.030 |
Why?
|
Intraoperative Complications | 2 | 2007 | 1186 | 0.030 |
Why?
|
Collagen | 2 | 2016 | 2635 | 0.030 |
Why?
|
Ileum | 1 | 1975 | 556 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1975 | 311 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1993 | 306 | 0.030 |
Why?
|
Leg Injuries | 2 | 1985 | 177 | 0.030 |
Why?
|
Retinoblastoma | 1 | 1995 | 317 | 0.030 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2002 | 1199 | 0.030 |
Why?
|
Autoantigens | 1 | 1996 | 877 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2016 | 1251 | 0.020 |
Why?
|
Intermittent Claudication | 3 | 2000 | 307 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 2 | 2001 | 1951 | 0.020 |
Why?
|
Dipeptides | 1 | 1994 | 410 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5120 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1995 | 1993 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 623 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9390 | 0.020 |
Why?
|
Hot Temperature | 2 | 1998 | 1435 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2014 | 428 | 0.020 |
Why?
|
Clusterin | 2 | 2001 | 71 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 1994 | 13456 | 0.020 |
Why?
|
Radiology, Interventional | 1 | 1995 | 475 | 0.020 |
Why?
|
Filtration | 2 | 1982 | 229 | 0.020 |
Why?
|
Patient Admission | 1 | 1998 | 1384 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2014 | 755 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 1998 | 1405 | 0.020 |
Why?
|
Nursing Homes | 1 | 1998 | 1076 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 1549 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1990 | 147 | 0.020 |
Why?
|
Chemical Industry | 1 | 2010 | 115 | 0.020 |
Why?
|
Heart Diseases | 2 | 2004 | 2810 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 1996 | 820 | 0.020 |
Why?
|
Boston | 3 | 2004 | 9283 | 0.020 |
Why?
|
Postoperative Period | 2 | 2006 | 1821 | 0.020 |
Why?
|
Fibrinolysis | 1 | 1991 | 332 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 1990 | 154 | 0.020 |
Why?
|
Prospective Studies | 6 | 2006 | 54265 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1991 | 292 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1994 | 1792 | 0.020 |
Why?
|
Dermis | 1 | 2011 | 202 | 0.020 |
Why?
|
Tissue Engineering | 2 | 2015 | 1866 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1201 | 0.020 |
Why?
|
Cell Survival | 2 | 2015 | 5796 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2002 | 7593 | 0.020 |
Why?
|
Cause of Death | 1 | 2000 | 3723 | 0.020 |
Why?
|
Stroke | 3 | 2003 | 9946 | 0.020 |
Why?
|
Anticoagulants | 2 | 2024 | 4899 | 0.020 |
Why?
|
Fiber Optic Technology | 1 | 1991 | 289 | 0.020 |
Why?
|
Sex Factors | 2 | 2000 | 10529 | 0.020 |
Why?
|
Transcription Factors | 2 | 2014 | 12100 | 0.020 |
Why?
|
Smoking | 2 | 2000 | 9070 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1956 | 0.020 |
Why?
|
Thrombectomy | 1 | 1994 | 708 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2000 | 3023 | 0.020 |
Why?
|
Hemostasis | 1 | 1991 | 468 | 0.020 |
Why?
|
Oligopeptides | 1 | 1994 | 1188 | 0.020 |
Why?
|
Reference Values | 3 | 2002 | 4920 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3448 | 0.020 |
Why?
|
Genomics | 1 | 2004 | 5790 | 0.020 |
Why?
|
Random Allocation | 1 | 1992 | 2393 | 0.020 |
Why?
|
Capillaries | 1 | 1991 | 745 | 0.020 |
Why?
|
Risk | 2 | 1999 | 9629 | 0.020 |
Why?
|
Solubility | 2 | 1999 | 1088 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1975 | 1266 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 1993 | 664 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1993 | 1679 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.020 |
Why?
|
Colon | 1 | 1975 | 1788 | 0.020 |
Why?
|
Kinetics | 1 | 1994 | 6378 | 0.020 |
Why?
|
Age Factors | 2 | 2000 | 18416 | 0.020 |
Why?
|
Necrosis | 1 | 1990 | 1612 | 0.020 |
Why?
|
Anesthesia | 1 | 1997 | 1584 | 0.020 |
Why?
|
von Willebrand Factor | 2 | 1999 | 673 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6067 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1991 | 3086 | 0.020 |
Why?
|
Binding Sites | 1 | 1994 | 6050 | 0.020 |
Why?
|
Obesity | 1 | 2007 | 12913 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2014 | 1589 | 0.020 |
Why?
|
Retroperitoneal Space | 1 | 1985 | 173 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2009 | 699 | 0.020 |
Why?
|
Suture Techniques | 1 | 1989 | 788 | 0.010 |
Why?
|
Surgical Equipment | 1 | 1984 | 57 | 0.010 |
Why?
|
Ankle | 2 | 1978 | 350 | 0.010 |
Why?
|
Cell Membrane | 1 | 2014 | 3683 | 0.010 |
Why?
|
Fasting | 2 | 2003 | 1603 | 0.010 |
Why?
|
Ureteral Obstruction | 1 | 1986 | 292 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11481 | 0.010 |
Why?
|
Fibula | 1 | 1986 | 265 | 0.010 |
Why?
|
Proteinuria | 1 | 2006 | 594 | 0.010 |
Why?
|
Arm Injuries | 1 | 1985 | 156 | 0.010 |
Why?
|
Patient Selection | 1 | 1996 | 4276 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1992 | 6242 | 0.010 |
Why?
|
Computers | 1 | 1986 | 595 | 0.010 |
Why?
|
Leg Ulcer | 2 | 1997 | 69 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81212 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3618 | 0.010 |
Why?
|
Hospital Mortality | 1 | 1997 | 5422 | 0.010 |
Why?
|
Prognosis | 4 | 2006 | 29640 | 0.010 |
Why?
|
Protein Conformation | 1 | 1991 | 3969 | 0.010 |
Why?
|
Blood Pressure | 5 | 1978 | 8523 | 0.010 |
Why?
|
Venae Cavae | 1 | 1982 | 41 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 2218 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 243 | 0.010 |
Why?
|
E2F1 Transcription Factor | 1 | 2002 | 178 | 0.010 |
Why?
|
Nuclear Matrix | 1 | 2001 | 30 | 0.010 |
Why?
|
Buffers | 1 | 2001 | 144 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2002 | 269 | 0.010 |
Why?
|
Textile Industry | 1 | 2001 | 74 | 0.010 |
Why?
|
Health Status | 1 | 1995 | 4084 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1984 | 863 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36230 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23366 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2001 | 426 | 0.010 |
Why?
|
Neutrophils | 1 | 1993 | 3770 | 0.010 |
Why?
|
Canada | 1 | 1986 | 2129 | 0.010 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 841 | 0.010 |
Why?
|
Tibia | 1 | 1986 | 1065 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1984 | 756 | 0.010 |
Why?
|
Hypertension | 1 | 2000 | 8595 | 0.010 |
Why?
|
Pulmonary Embolism | 3 | 1982 | 2544 | 0.010 |
Why?
|
Culture Media | 1 | 1981 | 899 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 704 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1981 | 596 | 0.010 |
Why?
|
Adolescent | 6 | 2004 | 87749 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2001 | 848 | 0.010 |
Why?
|
Massachusetts | 1 | 1992 | 8805 | 0.010 |
Why?
|
Aneurysm, Ruptured | 1 | 2004 | 460 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1649 | 0.010 |
Why?
|
Equipment and Supplies | 1 | 1981 | 275 | 0.010 |
Why?
|
Patient Readmission | 1 | 1993 | 3329 | 0.010 |
Why?
|
Biopsy | 2 | 2002 | 6775 | 0.010 |
Why?
|
Peroneal Nerve | 1 | 1998 | 76 | 0.010 |
Why?
|
Placebos | 1 | 2003 | 1672 | 0.010 |
Why?
|
Ethyldimethylaminopropyl Carbodiimide | 1 | 1997 | 3 | 0.010 |
Why?
|
Butylene Glycols | 1 | 1997 | 11 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8058 | 0.010 |
Why?
|
Hydroxy Acids | 1 | 1997 | 19 | 0.010 |
Why?
|
Pliability | 1 | 1997 | 58 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1999 | 302 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2001 | 961 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1997 | 154 | 0.010 |
Why?
|
Doppler Effect | 1 | 1977 | 12 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2005 | 12531 | 0.010 |
Why?
|
Fibronectins | 1 | 2001 | 721 | 0.010 |
Why?
|
Subclavian Steal Syndrome | 1 | 1977 | 20 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1997 | 508 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2001 | 829 | 0.010 |
Why?
|
Pressure | 1 | 1980 | 1155 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3697 | 0.010 |
Why?
|
Neural Conduction | 1 | 1998 | 441 | 0.010 |
Why?
|
Societies, Medical | 1 | 2009 | 3903 | 0.010 |
Why?
|
Propionates | 1 | 1997 | 182 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1998 | 466 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 2002 | 1434 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 2363 | 0.010 |
Why?
|
Blood Viscosity | 1 | 1976 | 124 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2004 | 1503 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1996 | 184 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1997 | 367 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3257 | 0.010 |
Why?
|
Ulcer | 1 | 1977 | 205 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 2256 | 0.010 |
Why?
|
Albuminuria | 1 | 1999 | 659 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2931 | 0.010 |
Why?
|
Permeability | 1 | 1997 | 719 | 0.010 |
Why?
|
Elasticity | 1 | 1997 | 652 | 0.010 |
Why?
|
Specialties, Surgical | 1 | 2000 | 389 | 0.010 |
Why?
|
Premenopause | 1 | 1999 | 1039 | 0.010 |
Why?
|
Blood | 1 | 1997 | 586 | 0.010 |
Why?
|
Temperature | 1 | 1981 | 2221 | 0.010 |
Why?
|
Anesthesia, Epidural | 1 | 1997 | 232 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2004 | 1529 | 0.010 |
Why?
|
Embolism | 1 | 1978 | 408 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 1984 | 2311 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 1996 | 631 | 0.010 |
Why?
|
Endarterectomy | 1 | 1974 | 196 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1663 | 0.010 |
Why?
|
Anesthesia, Spinal | 1 | 1997 | 280 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2002 | 2909 | 0.010 |
Why?
|
Motor Neurons | 1 | 1998 | 865 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1173 | 0.010 |
Why?
|
Anesthesia, General | 2 | 1997 | 1165 | 0.010 |
Why?
|
Graft Rejection | 1 | 1986 | 4423 | 0.010 |
Why?
|
Disease Progression | 2 | 2002 | 13503 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1998 | 2932 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2004 | 1927 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1997 | 1666 | 0.010 |
Why?
|
Duodenum | 1 | 1975 | 486 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1977 | 1516 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2138 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4286 | 0.010 |
Why?
|
Neuralgia | 1 | 1998 | 597 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7469 | 0.010 |
Why?
|
Ethanol | 1 | 1997 | 1323 | 0.010 |
Why?
|
Water | 1 | 1997 | 1402 | 0.010 |
Why?
|
Surgery, Plastic | 1 | 1978 | 640 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2696 | 0.010 |
Why?
|
Postmenopause | 1 | 1999 | 2503 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 1976 | 581 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12900 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10828 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10553 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12159 | 0.000 |
Why?
|
Insulin | 1 | 2003 | 6592 | 0.000 |
Why?
|
Acute Disease | 1 | 1998 | 7268 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2721 | 0.000 |
Why?
|
Glucose | 1 | 1998 | 4361 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15272 | 0.000 |
Why?
|
Odds Ratio | 1 | 1998 | 9714 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1984 | 77 | 0.000 |
Why?
|
Dilatation | 1 | 1986 | 307 | 0.000 |
Why?
|
Algorithms | 1 | 2005 | 13959 | 0.000 |
Why?
|
Pain | 1 | 1977 | 5066 | 0.000 |
Why?
|
Catheterization | 1 | 1986 | 1432 | 0.000 |
Why?
|
Jugular Veins | 1 | 1981 | 211 | 0.000 |
Why?
|
Cytomegalovirus Infections | 1 | 1984 | 831 | 0.000 |
Why?
|
Constriction | 1 | 1977 | 171 | 0.000 |
Why?
|
Fluoroscopy | 1 | 1981 | 943 | 0.000 |
Why?
|
Blood Volume | 1 | 1977 | 550 | 0.000 |
Why?
|
Cardiac Output | 1 | 1977 | 837 | 0.000 |
Why?
|
Wounds, Penetrating | 1 | 1976 | 306 | 0.000 |
Why?
|
Neoplasms | 1 | 1982 | 22066 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1984 | 3145 | 0.000 |
Why?
|
Hypotension | 1 | 1977 | 883 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1986 | 12968 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1982 | 2041 | 0.000 |
Why?
|
Child | 2 | 1983 | 79759 | 0.000 |
Why?
|
Infant | 1 | 1983 | 36032 | 0.000 |
Why?
|
Child, Preschool | 1 | 1983 | 42036 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1977 | 15739 | 0.000 |
Why?
|